Appointment booking for Dr. James Vandewall, MD is currently not available.Dr. James Vandewall, MD has not yet fully activated their profile on DiabetesIQ.
Dr. James Vandewall, MD (he/him) is a Rheumatologist in Olean, NY with over 19 years of experience. What is your opinion of Dr. James Vandewall, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. James Vandewall, MD has received over $5,856 which includes payments from the following companies:
$968.81 from Pfizer Inc.
$594.72 from Janssen Biotech, Inc.
$594.53 from Celgene Corporation
$526.73 from E.R. Squibb & Sons, L.L.C.
$477.78 from Amgen Inc.
$432.47 from Genentech USA, Inc.
$386.76 from Novartis Pharmaceuticals Corporation
$354.24 from AbbVie, Inc.
$288.68 from GlaxoSmithKline, LLC.
$254.15 from LILLY USA, LLC
$228.07 from Mallinckrodt LLC
$212.06 from UCB, Inc.
$134.40 from Horizon Pharma plc
$86.69 from Alexion Pharmaceuticals, Inc.
$74.43 from Crealta Pharmaceuticals LLC
$57.28 from Boehringer Ingelheim Pharmaceuticals, Inc.
$49.51 from Bioventus LLC
$35.64 from Sobi, Inc
$28.35 from GENZYME CORPORATION
$17.92 from Antares Pharma, Inc.
Payments received by Dr. James Vandewall, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!